Skip to main content

Table 1 Detailed baseline characteristics of the study population for the HHPCP and CSPPT cohort

From: The association of serum betaine concentrations with the risk of new-onset cancers: results from two independent nested case-control studies

Variables

Controls (n = 1391)

Cases (n = 1391)

p value

Controls (n = 114)

Cases (n = 114)

p value

Male, n (%)

779 (56.0)

776 (55.8)

0.939

56 (49.1)

56 (49.1)

1.000

Age, y

69.35 (7.78)

69.35 (7.78)

0.998

60.85 (7.14)

60.86 (7.12)

0.988

BMI, kg/m2

25.57 (23.19, 28.07)

25.46 (23.12, 28.07)

0.525

25.23 (23.31, 27.46)

24.72 (22.76, 27.24)

0.231

Family history of cancer

47 (3.4)

50 (3.6)

0.836

0 (0.0)

1 (0.9)

1.000

Baseline SBP, mmHg

147.33 (133.83, 160.33)

146.00 (131.67, 161.00)

0.314

162.33 (154.67, 180.00)

162.00 (150.67, 172.50)

0.205

Baseline DBP, mmHg

83.00 (76.33, 90.33)

82.67 (75.00, 91.00)

0.249

96.67 (90.00, 101.83)

94.00 (86.50, 100.67)

0.281

History of diabetes, yes, no. (%)

137 (9.8)

191 (13.7)

0.002

7 (6.1)

3 (2.6)

0.332

Smoking status (%)

  

0.011

  

0.079

 Current

334 (24.0)

401 (28.8)

 

33 (28.9)

49 (43.0)

 

 Former

160 (11.5)

163 (11.7)

 

8 (7.0)

5 (4.4)

 

 Never

897 (64.5)

827 (59.5)

 

73 (64.0)

60 (52.6)

 

Alcohol consumption status (%)

  

0.359

  

0.735

 Current

388 (27.9)

370 (26.6)

 

33 (28.9)

30 (26.3)

 

 Former

62 (4.5)

77 (5.5)

 

8 (7.0)

11 (9.6)

 

 Never

941 (67.6)

944 (67.9)

 

73 (64.0)

73 (64.0)

 

TC, mg/dL

6.27 (5.38, 7.22)

6.36 (5.53, 7.23)

0.066

5.51 (4.81, 6.16)

5.51 (4.72, 6.16)

0.838

TG, mg/dL

1.14 (0.80, 1.75)

1.18 (0.81, 1.71)

0.409

1.42 (1.19, 1.98)

1.48 (1.17, 1.96)

0.691

HDL-C, mg/dL

1.16 (0.99, 1.36)

1.19 (1.03, 1.36)

0.033

1.19 (1.04, 1.47)

1.25 (1.04, 1.43)

0.785

Glucose, mmol/L

5.80 (5.30, 6.50)

5.80 (5.30, 6.50)

0.826

5.72 (5.22, 6.41)

5.46 (5.06, 6.12)

0.120

Homocysteine, µg/mL

12.01 (10.31, 14.66)

12.25 (10.06, 15.02)

0.904

13.00 (10.64, 17.00)

12.77 (10.17, 16.36)

0.389

Folate, ng/mL

6.14 (4.00, 9.65)

6.12 (4.23, 10.12)

0.437

6.80 (5.25, 9.76)

7.78 (4.98, 9.81)

0.601

MTHFR C677T

  

0.014

  

0.590

 CC

339 (24.4)

288 (20.7)

 

26 (22.8)

24 (21.1)

 

 CT

832 (59.8)

837 (60.2)

 

59 (51.8)

54 (47.4)

 

 TT

220 (15.8)

266 (19.1)

 

29 (25.4)

36 (31.6)

 

Betaine, µg/mL

5.73 (4.57, 7.11)

5.80 (4.58, 7.26)

0.401

9.38 (7.09, 11.83)

10.15 (8.30, 13.66)

0.036

  1. Abbreviations: BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; TC: total cholesterol; TG: triglycerides; HDL-C: high-density lipoprotein cholesterol; and MTHFR: methylenetetrahydrofolate reductase. Continuous variables are presented as median (quantile 1- quantile 3), categorical variables are presented as n (%). Differences in baseline characteristics between cases and controls were compared using chi2 tests for categorical variables and generalized paired t-tests and nonparametric Kruskal-Wallis tests for continuous variables